EU regulatory news highlights February 2026

5 March 2026 From the regulatory newsfeeds of the European Medicines Agency’s (EMA), the European Commission (EC) and the Heads of Medicine Agencies (HMA), Arex Advisor has rounded up a selection of highlights from the past month. EMA CHMP sets priorities in 2026 workplan 2 February 2026The Committee for Medicinal Products for Human Use (CHMP) […]